Prospective Study Assessing Patient Satisfaction of Symptom Control With Proton Pump Inhibitor Dosing Regimen

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The overall aim of this study is to assess if patients with persistent GERD symptoms receiving sub-optimal omeprazole dosing experience improvement in GERD symptoms when prescribed an optimal dosing regimen. The optimal dosing regimen is defined as taking omeprazole 30 minutes prior to the first meal of the day.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: MetroHealth Medical Center
• Treatments: Omeprazole; Proton Pump Inhibitors

Criteria

Inclusion Criteria:

• ≥ 18 years old

• taking omeprazole 20 mg

• episodic heartburn at least 3 times per week

• provides consent and be willing to complete study questionnaires

• read, speak and write English

Exclusion Criteria:

• weight loss (alarm symptom)

• normal esophagogastroduodenoscopy (EGD) in last one year

• pregnant or women planning on becoming pregnant at any time during the study

• history of Barrett's esophagus

• prior esophageal strictures

• intolerance/allergy to study medications

• patients on plavix or a history of upper gastrointestinal surgery

• investigators or their immediate family (spouse, children, sibling)